SCHEMBL4741115

SCHEMBL4741115

NC(=O)c1ccc(-c2nc(N)nc3c2-c2cc(NS(=O)(=O)c4ccc(F)cc4F)c(Cl)cc2CC3)cc1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.40
PIK3CA P42336 12/20 0.39
MTOR P42345 5/20 0.39
CCR2 P41597 2/20 0.37
BRAF P15056 1/20 0.36
MAPK14 Q16539 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PIK3CG P48736 3/20 0.35
PIK3CB P42338 2/20 0.35
PIK3C3 Q8NEB9 1/20 0.35
PI4KA P42356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787508 0.93 PIK3CD (0.44) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4738329 0.92 PIK3CA (0.42) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4740778 0.92 CCR2 (0.39) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4739014 0.90 PI4KA (0.42) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL14148281 0.89 PIK3CA (0.48) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4737748 0.89 PIK3C3 (0.42) PIK3CDPIK3CAMTORBRAFPIK3C3
SCHEMBL4787518 0.88 CCR2 (0.41) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4740239 0.88 PIK3CA (0.45) PIK3CDPIK3CAMTORBRAFPIK3CG
SCHEMBL4741753 0.87 CCR2 (0.42) PIK3CDPIK3CAMTORCCR2BRAF
SCHEMBL4736805 0.86 PIK3CD (0.39) PIK3CDPIK3CAMTORCCR2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed